Sarcopenia and Aging
The mechanisms of action and indications of currently available FDA-approved therapeutic agents will be reviewed. New agents in development will be discussed.
Initial Date: May 19, 2018 in New Orleans, LA
at NOF's Interdisciplinary Symposium on Osteoporosis (ISO) 
Expiration Date: December 31, 2020
Credits Available: 1.0 hours
Fee: $25 Non-Member, $20 Member

Faculty: Neil Binkley, MPH; Nothing to disclose

Activity Description
The mechanisms of action and indications of currently available FDA-approved therapeutic agents will be reviewed. New agents in development will be discussed.  

Target Audience
This continuing education activity is intended for use by health professionals who participate in the care of patients at risk for or suffering from osteoporosis, in the areas of primary care, endocrinology, geriatrics, gynecology, internal medicine, obstetrics, orthopedics, osteopathy, pediatrics, physiatry, radiology, rheumatology and physical therapy.

This includes physicians, nurse practitioners, registered nurses, pharmacists, physician assistants, technologists, researchers, public health professionals and health educators with an interest in osteoporosis and bone health.

Objectives 
1. 
Describe the impact of sarcopenia and aging
2. Compare the effectiveness of various FDA-approved drugs available for prevention and treatment of sarcopenia
3. Discuss pharmaceutical agents currently in development for sarcopenia 

          Accreditation

          The National Osteoporosis Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Osteoporosis Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

          The National Osteoporosis Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The National Osteoporosis Foundation designates this educational activity for a maximum of 1.0 continuing nursing education credit(s).

          Other healthcare providers will also be able to receive a certificate of completion; nurse practitioners and physician assistants may request an AMA PRA Category 1 Credit(s)™ certificate of participation.

          CME Program Eligibility
          Method of Participation in the Learning Process: Clinician learners will view and analyze the subject matter, conduct additional informal research through related internet searches on the subject matter, and complete a post-test assessment of knowledge and skills gained as a result of the activity. 

          After participating in this activity, the reader has the option of taking a post-test with a passing grade of 70% or better to qualify for continuing education credit for this activity. It is estimated it will take 1.0 hour(s) to complete the reading and take the post-test. Continuing education credit will be available for two years from the date of publication. 


          Disclosure of Commercial Support
          It is the policy of the National Osteoporosis Foundation (NOF) to ensure balance, independence, objectivity, and scientific rigor in all its sponsored publications and programs. NOF requires the disclosure of the existence of any significant financial interest or any other relationship the sponsor, Editorial Board or Guest Contributors have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. All authors and contributors to this continuing education activity have disclosed any real or apparent interest that may have direct bearing on the subject matter of this program.

          Please be advised that NOF’s accreditation status with ACCME and ANCC does not imply endorsement by NOF, ACCME or ANCC of any commercial products displayed in conjunction with this activity or endorsement of any point of view.


          Refund Policy
          NOF offers no returns or refunds on online internet CME activities purchased through our store. All sales are final. Meeting and workshop registrations will be refunded in accordance with the cancellation policy of the meeting and/or workshop, as outlined at registration.




          Type:     Internet Activity (Enduring Material)
          101 Registered Users

          National Osteoporosis Foundation

          251 18th Street South, Suite 630, Arlington, VA 22202 I [p] 1 (800) 231-4222 • [f] 1 (703) 414-3742

          The National Osteoporosis Foundation is a qualified 501(c)(3) tax-exempt organization and all donations to the organization are
          tax deductible to the full extent allowable by law. NOF’s tax ID number is 36-3350532.